Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Hatching from the cocoon: US FDA embraces the world

This article was originally published in Scrip

Executive Summary

Facing the reality that 80% of the active ingredients in prescription drugs consumed by the US public comes from overseas, let alone a large portion of the nation's food supply, the US FDA in recent years has been taking steps to move from being mostly a homeland-focused regulator to engaging the rest of the world – breaking out of its insulated cocoon at its White Oak compound in Silver Spring, Maryland and setting up shop where the action is, like Mumbai, India; Guangzhou, China; Amman, Jordan; Pretoria, South Africa; and Santiago, Chile.






Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts